Web Version

Rapidly spreading variants of SARS-CoV-2 that have arisen in the United Kingdom, South Africa and Brazil (B.1.1.7, B.1.351, P.1) share the spike N501Y substitution, which is of particular concern because it is located in the viral receptor binding site for cell entry and increases binding to the receptor.
BioCat offers a variety of tools to accelerate critical research and enhance understanding of the biology of SARS-CoV-2 variants.

SARS-CoV-2 Additional Genome Coverage Amplicon Panel

The use of overlapping primers results in 99.7% coverage of the genome and ensures that novel SARS-CoV-2 variants are detected by NGS, even when the mutation is a dropout of genomic sequence.

SARS-CoV-2 Spike Mutant Recombinant Proteins

Our comprehensive collection of recombinant SARS-CoV-2 spike mutants allows for the evaluation of the efficacy of antibodies and vaccination.

SARS-CoV-2 Spike Mutant-Pseudotyped Lentivirus Products

SARS-CoV-2 spike protein-pseudotyped lentiviral products enable assays in a biosafety level 2 laboratory to study virus-receptor interaction and to measure how antibodies or other compounds affect viral binding and entry.

BioCat GmbH

Im Neuenheimer Feld 584
D-69120 Heidelberg
Tel:  +49 (0) 6221 7141516
Fax: +49 (0) 6221 7141529
Email: info@biocat.com
Web: https://www.biocat.com